Clorazepic Acid

CHEMBL1213252 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

314.7 g/mol

LogP

3.3

Phase

4

A benzodiazepine-related compound that acts on the central nervous system to produce calming effects. It is used to treat anxiety disorders and may also help manage withdrawal symptoms.

Molekularmasse

314,7200 g/mol

LogP

3,30

TPSA

78,80 Å²

Lipinski-Regel der Fünf

Bestanden

Wirkmechanismus

Enhances the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors by binding to an allosteric site and increasing the frequency of chloride ion channel opening. This produces anxiolytic, sedative, hypnotic, and anticonvulsant effects.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Enhances the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors by binding to an allosteric site and increasing the frequency of chloride ion channel opening. This produces anxiolytic, sedative, hypnotic, …

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O

InChI

InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)

Molecular Formula

C16H11ClN2O3

HBD / HBA

2 / 4

Rotierbare Bindungen

2

Schwere Atome

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A benzodiazepine-related compound that acts on the central nervous system to produce calming effects. It is used to treat anxiety disorders and may also help manage withdrawal symptoms.

Enhances the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors by binding to an allosteric site and increasing the frequency of chloride ion channel opening. This produces anxiolytic, sedative, hypnotic, and anticonvulsant effects.

Yes, Clorazepic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1213252. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 2809. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Clorazepic Acid auf PillFYI

Struktur

Schnelldaten

Formel: C16H11ClN2O3

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.